Topoisomerase I poisons-induced autophagy: Cytoprotective, Cytotoxic or Non-protective
Topoisomerase I inhibitors represent a widely used class of antineoplastic agents that promote both single-stranded and double-stranded breaks in the DNA of tumor cells, leading to tumor cell death. Topotecan and irinotecan are the clinically relevant derivatives of the parent drug, camptothecin. As...
Main Authors: | Ahmed M. Elshazly, Polina A. Wright, Jingwen Xu, David A. Gewirtz |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Autophagy Reports |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/27694127.2022.2155904 |
Similar Items
-
The Cytoprotective, Cytotoxic and Nonprotective Functional Forms of Autophagy Induced by Microtubule Poisons in Tumor Cells—Implications for Autophagy Modulation as a Therapeutic Strategy
by: Jingwen Xu, et al.
Published: (2022-07-01) -
Cytoprotective, Cytotoxic and Cytostatic Roles of Autophagy in Response to BET Inhibitors
by: Ahmed M. Elshazly, et al.
Published: (2023-08-01) -
The Cytoprotective Role of Autophagy in Response to BRAF-Targeted Therapies
by: Ahmed M. Elshazly, et al.
Published: (2023-09-01) -
Is Autophagy Inhibition in Combination with Temozolomide a Therapeutically Viable Strategy?
by: Ahmed M. Elshazly, et al.
Published: (2023-02-01) -
The Switch between Protective and Nonprotective Autophagy; Implications for Autophagy Inhibition as a Therapeutic Strategy in Cancer
by: David A. Gewirtz
Published: (2020-01-01)